Seki Y, Shibutani M, Tanda H, Tsukida T, et al. Impact of the Immunonutritional Status on the Feasibility of Subsequent Treatment After the Discontinuation of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients With Metastatic Colorectal Cancer. Anticancer Res 2026;46:1117-1122.
PMID: 41617427